Item 1A. Risk Factors

There have been no material changes from the significant risk factors and uncertainties previously disclosed under the heading "Risk Factors" in the Company's annual report on Form 10-K for the year ended December 31, 2025, that if they were to occur, could materially adversely affect the Company’s business, financial condition, operating results and/or cash flow. For a discussion of the Company’s risk factors, refer to Item 1A. “Risk Factors” contained in the Company’s annual report on Form 10-K for the year ended December 31, 2025.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

MOODY'S PURCHASES OF EQUITY SECURITIES

For the three months ended March 31, 2026


Period	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Program	Approximate Dollar Value of Shares That May Yet be Purchased Under the Program(2)
January 1- 31	236,102	$	526.15	235,831	$	3,836	million
February 1- 28	693,319	$	450.20	692,653	$	3,525	million
March 1- 31	2,559,104	$	443.94	2,331,610	$	2,489	million
Total	3,488,525	$	451.22	3,260,094

(1) Includes surrender to the Company of 271; 666; and 227,494 shares of common stock in January, February, and March, respectively, to satisfy tax withholding obligations in connection with the vesting of restricted stock issued to employees.

(2) As of the last day of each of the months. On October 21, 2025, the Board authorized $4 billion in share repurchase authority. At March 31, 2026 there was approximately $2.5 billion of share repurchase authority remaining under this authorization. There is no established expiration date for the remaining authorization.

During the first quarter of 2026, Moody’s issued a net 394 thousand shares under employee stock-based compensation plans.

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information